Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 14 | 8 | 20 | 64 | 152 |
| Gross Profit | 14 | 8 | 20 | 64 | 152 |
| Operating Expenses | 3,974 | 2,977 | 3,852 | 6,341 | 6,401 |
| Operating Income | -3,960 | -2,969 | -3,832 | -6,277 | -6,249 |
| Other Income | 19 | 9 | 46 | 72 | 159 |
| Pre-tax Income | -3,941 | -2,960 | -3,786 | -6,205 | -6,090 |
| Net Income Continuous | -3,941 | -2,960 | -3,786 | -6,205 | -6,090 |
| Net Income Discontinuous | N/A | N/A | -160 | N/A | -40 |
| Net Income | $-3,941 | $-2,960 | $-3,946 | $-6,205 | $-6,130 |
| EPS Basic Total Ops | -2.60 | -2.00 | -2.60 | -4.00 | -4.00 |
| EPS Basic Continuous Ops | -2.54 | -1.92 | -2.37 | -4.03 | -4.00 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.10 | N/A | -0.03 |
| EPS Diluted Total Ops | -2.60 | -2.00 | -2.60 | -4.00 | -4.00 |
| EPS Diluted Continuous Ops | -2.54 | -1.92 | -2.37 | -4.03 | -4.00 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.10 | N/A | -0.03 |
| EBITDA(a) | $-3,873 | $-2,874 | $-3,730 | $-6,171 | $-6,143 |